Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.

Frontiers in endocrinology·2026
Same author

Evaluating pain and neurological function with high frequency 10 kHz spinal cord stimulation in the treatment of painful diabetic neuropathy: design of a multicentre, randomised controlled trial (PDN-Sensory).

BMJ open·2025
Same author

Switch of Open-Source Automated Insulin Delivery (AID) System-AndroidAPS to Commercially Available AID Systems in Type 1 Diabetes: The Extension of the CODIAC Study.

Diabetes technology & therapeutics·2025
Same author

Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies.

Journal of diabetes science and technology·2025
Same author

Standing balance impairment in persons with type 2 diabetes is predicted by peripheral neuropathy and vestibulopathy.

Primary care diabetes·2024
Same author

Retrospective derivation of a causal pathway for diabetic ketoacidosis in adult patients with type 2 diabetes mellitus.

BMJ open diabetes research & care·2024

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

2.2K

[Quo vadis diabetes technology?]

George Grunberger

    Casopis Lekaru Ceskych
    |December 8, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Continuous glucose monitoring and smart insulin pumps offer improved diabetes management. These integrated systems automate insulin delivery for better glycemic control and reduced hypoglycemia, marking a new era in diabetes care.

    Keywords:
    automated insulin delivery patient education.continuous glucose monitoringdiabetes technologyinsulin pumps

    More Related Videos

    Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
    10:09

    Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

    Published on: May 11, 2015

    10.1K
    Improving IV Insulin Administration in a Community Hospital
    12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    19.4K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
    08:16

    Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

    Published on: March 15, 2024

    2.2K
    Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
    10:09

    Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

    Published on: May 11, 2015

    10.1K
    Improving IV Insulin Administration in a Community Hospital
    12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    19.4K

    Area of Science:

    • Endocrinology
    • Biomedical Engineering
    • Diabetes Technology

    Background:

    • Diabetes management has evolved from urine glucose monitoring to advanced technologies.
    • Current intensive insulin therapy involves multiple daily injections or insulin pumps.
    • Continuous glucose monitoring (CGM) and insulin pumps represent significant advancements.

    Purpose of the Study:

    • To review the feasibility and impact of integrated continuous glucose monitoring and insulin pump systems.
    • To discuss patient selection criteria for advanced diabetes technology.
    • To explore challenges in integrating these technologies into clinical practice.

    Main Methods:

    • Review of key research studies on integrated CGM and insulin pump systems.
    • Analysis of data demonstrating the feasibility of automated insulin delivery.
    • Discussion of clinical trial outcomes and future directions.

    Main Results:

    • Integrated systems show feasibility for automated insulin delivery.
    • Smart insulin pumps can achieve more stable glycemic control.
    • These technologies have the potential to minimize hypoglycemic episodes.

    Conclusions:

    • The integration of CGM and insulin pumps heralds a new era in diabetes management.
    • Careful patient selection and addressing implementation challenges are crucial for success.
    • Further research and clinical trials are essential for optimizing these advanced diabetes technologies.